How Acute Lymphoblastic Leukemia Is Diagnosed

Acute lymphoblastic leukemia (ALL) is a fast-growing cancer of the blood and bone marrow. It involves immature white blood cells called lymphoblasts. Diagnosing ALL typically starts with a physical exam and blood tests. If these suggest ALL, a bone marrow biopsy is usually performed to confirm the diagnosis and identify the specific type, guiding treatment decisions.

What is How Acute Lymphoblastic Leukemia Is Diagnosed?

Acute lymphoblastic leukemia (ALL) is a type of cancer that affects your blood and bone marrow. It is called "acute" because it develops quickly, and "lymphoblastic" because it involves immature white blood cells called lymphoblasts. Diagnosing ALL means finding out if you have this cancer and what specific type it is, which is crucial for planning the most effective treatment.

ALL starts in the bone marrow, the soft inner part of your bones where new blood cells are made. In ALL, the body produces too many abnormal, immature white blood cells (lymphoblasts) that do not work correctly. These abnormal cells multiply rapidly and can crowd out healthy blood cells, leading to various symptoms. Because these abnormal cells cannot fight infection properly and can interfere with the production of red blood cells and platelets, people with ALL often experience symptoms like fatigue, frequent infections, and easy bruising or bleeding. The diagnostic process aims to identify these abnormal cells and determine their characteristics. The diagnosis of ALL is a multi-step process. It typically begins with a review of your symptoms and a physical examination. If ALL is suspected, doctors will order specific blood tests and, most importantly, a bone marrow biopsy to confirm the presence of leukemia cells and understand their genetic makeup. This detailed information helps doctors classify the leukemia and choose the best treatment plan for you.

Symptoms

Symptoms of acute lymphoblastic leukemia (ALL) often appear suddenly and can be vague, resembling those of other common illnesses. These symptoms arise because the abnormal leukemia cells crowd out healthy blood cells in the bone marrow. Common signs include feeling very tired, having frequent infections, or noticing unusual bruising or bleeding.

Many symptoms of ALL are due to a shortage of healthy blood cells. For example, a lack of red blood cells (anemia) can cause you to feel very tired, weak, or short of breath, and your skin might look pale. This happens because red blood cells carry oxygen throughout your body. If you have too few healthy white blood cells, your body struggles to fight off germs, leading to frequent infections and fevers. A low number of platelets, which help blood clot, can cause easy bruising, nosebleeds, or bleeding from the gums. You might also notice small red or purple spots on your skin called petechiae. Other symptoms can include bone or joint pain, especially in children, as leukemia cells build up in these areas. You might also have swollen lymph nodes (small glands that are part of your immune system), or an enlarged liver or spleen, which can cause discomfort or a feeling of fullness in your abdomen. Unexplained weight loss or loss of appetite can also occur.

Causes & risk factors

The exact cause of acute lymphoblastic leukemia (ALL) is often unknown, and in most cases, it is not inherited. ALL happens when there are changes (mutations) in the DNA of blood-forming cells in the bone marrow. While the specific reason for these changes is usually unclear, certain factors can increase a person's risk of developing ALL.

Most cases of ALL occur without any clear reason, and it is not typically passed down through families. It is believed that a combination of genetic and environmental factors may play a role, but often, no specific cause can be identified. The DNA mutations that lead to ALL are usually acquired during a person's lifetime, rather than being inherited from parents. Some known risk factors include exposure to very high levels of radiation, such as from previous radiation therapy for other cancers. Exposure to certain chemicals, like benzene, has also been linked to an increased risk. However, these exposures account for only a small number of ALL cases. Certain genetic syndromes can also increase the risk of ALL. For example, people with Down syndrome have a higher chance of developing ALL. Having a brother or sister, especially an identical twin, with ALL also slightly increases risk. However, it is important to remember that most people with these risk factors never develop ALL, and many people with ALL have no known risk factors.

How it's diagnosed

Diagnosing acute lymphoblastic leukemia (ALL) involves several steps, starting with a physical exam and blood tests. If these initial tests suggest ALL, a bone marrow aspiration and biopsy are performed to confirm the diagnosis. Further tests, such as a lumbar puncture and genetic analyses, help determine the extent of the disease and guide treatment decisions.

The diagnostic process usually begins with your doctor asking about your symptoms and performing a physical exam. During the exam, your doctor will check for signs like pale skin, swollen lymph nodes in your neck, armpits, or groin, and an enlarged liver or spleen. These findings can suggest the presence of leukemia. Blood tests are the next crucial step. A complete blood count (CBC) measures the number of red blood cells, white blood cells, and platelets. In ALL, a CBC often shows a low number of red blood cells (anemia) and platelets, along with an abnormal number of white blood cells, often with many immature cells called blasts. A peripheral blood smear involves looking at a drop of your blood under a microscope to identify these abnormal blast cells. The definitive diagnosis of ALL requires a bone marrow aspiration and biopsy. This procedure involves taking a small sample of liquid bone marrow (aspiration) and a small piece of solid bone marrow (biopsy), usually from the back of your hip bone. These samples are then examined under a microscope to confirm the presence of leukemia cells and determine the percentage of blast cells, which is key for diagnosis. Once ALL is confirmed, further tests are done to understand the specific type of leukemia and if it has spread. A lumbar puncture (spinal tap) involves taking a small sample of fluid from around your spinal cord to check for leukemia cells in the central nervous system (brain and spinal cord). Genetic tests, such as cytogenetics, FISH (fluorescence in situ hybridization), and PCR (polymerase chain reaction), are performed on bone marrow samples to look for specific chromosome changes or gene mutations. These genetic markers are vital for classifying the ALL and predicting how it might respond to different treatments.

Treatment options

Treatment for acute lymphoblastic leukemia (ALL) is complex and depends on factors like your age, the specific type of ALL, and whether it has spread. The main goal is to destroy leukemia cells and prevent their return. Common treatments include chemotherapy, targeted therapy, immunotherapy, and sometimes a stem cell transplant.

Chemotherapy is the primary treatment for most people with ALL. It uses powerful drugs to kill fast-growing cancer cells throughout the body. Chemotherapy is typically given in phases, starting with an intensive induction phase to achieve remission (where no leukemia cells are found), followed by consolidation and maintenance phases to prevent the cancer from returning. Targeted therapy uses drugs that specifically attack certain vulnerabilities in cancer cells, often based on the genetic changes found in the leukemia. Immunotherapy helps your body's own immune system fight the cancer. For example, some immunotherapies use modified immune cells or antibodies to recognize and destroy leukemia cells. In some cases, especially for high-risk ALL or if the cancer returns, a stem cell transplant (also called a bone marrow transplant) may be recommended. This procedure replaces diseased bone marrow with healthy blood-forming stem cells, usually from a donor. Radiation therapy, which uses high-energy beams to kill cancer cells, is rarely used for ALL but may be an option if the cancer has spread to the brain or spinal cord, or in preparation for a stem cell transplant.

Recovery & outlook

The recovery and outlook for acute lymphoblastic leukemia (ALL) have significantly improved over the years, especially for children. The prognosis depends on several factors, including your age, the specific genetic changes in the leukemia cells, and how well the cancer responds to initial treatment. Many people achieve long-term remission or are cured.

For children, the outlook for ALL is generally very good, with a high percentage achieving long-term remission or cure. For adults, the outlook is more varied but has also improved considerably with advances in treatment. Your medical team will discuss your specific prognosis based on the detailed diagnostic information from your tests. Achieving remission means that there are no detectable leukemia cells in your bone marrow and blood, and your blood counts have returned to normal. However, even after remission, ongoing treatment (maintenance therapy) is crucial to prevent the leukemia from returning. This phase can last for several years. Regular follow-up appointments and tests are important after treatment to monitor for any signs of the leukemia returning and to manage any long-term side effects from treatment. Your care team will provide guidance on lifestyle adjustments and support resources to help you through recovery.

When to see a doctor

You should see a doctor if you experience persistent or worsening symptoms that could indicate acute lymphoblastic leukemia (ALL). These include unexplained fever, unusual bruising or bleeding, severe fatigue that doesn't improve with rest, persistent bone or joint pain, or noticeably swollen lymph nodes. Early diagnosis is important for effective treatment.

While many of these symptoms can be caused by less serious conditions, it is important to have them checked by a healthcare professional, especially if they are new, severe, or do not go away. For example, if you have a fever that lasts for several days without a clear cause, or if you notice bruises appearing without injury, it warrants medical attention. Do not delay seeking medical advice if you experience a combination of these symptoms. Your doctor can perform initial tests, such as a blood count, to help determine the cause of your symptoms. If ALL is suspected, they will refer you to a specialist for further evaluation and diagnosis. Remember, this information is for general guidance. Only a qualified clinician can diagnose your condition and recommend appropriate care. If you are concerned about any symptoms, please consult your doctor promptly.

Frequently asked questions

What is the first test usually done to diagnose ALL?

The first test usually done to diagnose acute lymphoblastic leukemia (ALL) is a complete blood count (CBC) and a peripheral blood smear. These blood tests check the number and appearance of your blood cells, looking for abnormal white blood cells (blasts) and low counts of red blood cells and platelets.

Is ALL an inherited condition?

In most cases, acute lymphoblastic leukemia (ALL) is not an inherited condition. It typically results from genetic changes (mutations) that happen during a person's lifetime, rather than being passed down from parents. Only a small percentage of cases are linked to inherited genetic syndromes.

How long does it take to get an ALL diagnosis?

The time it takes to get an acute lymphoblastic leukemia (ALL) diagnosis can vary. Initial blood tests can suggest ALL quickly, often within a day or two. However, confirming the diagnosis with a bone marrow biopsy and performing additional genetic tests to classify the specific type of ALL can take several days to a week or more.

Can ALL be diagnosed without a bone marrow biopsy?

While blood tests can strongly suggest acute lymphoblastic leukemia (ALL), a bone marrow aspiration and biopsy are almost always necessary to confirm the diagnosis. This procedure allows doctors to directly examine the bone marrow for leukemia cells, determine their percentage, and perform crucial genetic tests that guide treatment.

What is the purpose of a lumbar puncture in ALL diagnosis?

A lumbar puncture (spinal tap) is performed in acute lymphoblastic leukemia (ALL) diagnosis to check if leukemia cells have spread to the central nervous system (the brain and spinal cord). This information is vital because if cancer cells are present, specific treatment is needed to target them in this area.

Are there different types of ALL, and do they affect diagnosis?

Yes, there are different types of acute lymphoblastic leukemia (ALL), primarily classified by the specific genetic changes found in the leukemia cells. While the initial diagnostic steps are similar, detailed genetic tests on bone marrow samples are crucial to identify these subtypes. This classification significantly affects treatment choices and prognosis.

Sources

• MedlinePlus — How Acute Lymphoblastic Leukemia Is Diagnosed
• Mayo Clinic — How Acute Lymphoblastic Leukemia Is Diagnosed
• Cochrane Library — How Acute Lymphoblastic Leukemia Is Diagnosed